Standard BioTools (LAB) Q2 2026 Earnings Report

477 Followers

LAB Q2 2026 EPS Results

Actual EPS-$0.07

Consensus EPS-$0.01

Beat/MissMissed by -$0.06

One Year Ago EPS-$0.05

Actual Revenue$20.10M

Expected Revenue$20.80M

Beat/MissMissed by -$700.00K

YoY Revenue Growth-7.62%

QuarterQ2 2026

Date08/05/2026

TimeAfter Close

Conference CallWednesday, August 5, 2026

LAB Upcoming Earnings

Standard BioTools's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 10, 2026	2026 (Q3)	-0.02 / -	-0.09	―
Aug 05, 2026	2026 (Q2)	-0.01 / -0.07	-0.05	-40.00% (-0.02)
May 05, 2026	2026 (Q1)	-0.05 / -0.04	-0.07	42.86% (+0.03)
Feb 24, 2026	2025 (Q4)	-0.05 / 0.04	-0.09	144.44% (+0.13)
Nov 04, 2025	2025 (Q3)	-0.04 / -0.09	-0.07	-28.57% (-0.02)
Aug 11, 2025	2025 (Q2)	-0.07 / -0.05	-0.12	58.33% (+0.07)
May 06, 2025	2025 (Q1)	-0.06 / -0.07	-0.27	74.07% (+0.20)
Feb 26, 2025	2024 (Q4)	-0.06 / -0.09	-0.25	64.00% (+0.16)
Oct 30, 2024	2024 (Q3)	-0.09 / -0.07	-0.27	74.07% (+0.20)
Jul 31, 2024	2024 (Q2)	-0.08 / -0.12	-0.22	45.45% (+0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed